Nadine Wong

Nadine Wong has a MBA from Simmons College, Boston, MA. She has accumulated many years of financial experience as an analyst from several industries such as the high tech industry, biotech industry and retail. Nadine also writes a biotech column for Biospace.com.

Read More

Celgene (CELG)

This biotech is growing at double-digit rates, just settled a major patent litigation suit, and 16 of its 19 analysts rate the stock a ‘buy’ or ‘strong buy’. Celgene (CELG) From Wong’s BioTech Stock Report Celgene’s (CELG) core business has three franchises, hematologic malignancy, solid and...
Read More